Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melvin Sanicas

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
The Pan African Medical Journal|July 11, 2017
[Innovations in vaccinology: challenge and opportunities for Africa]Doudou Diop, Melvin Sanicas
The Pan African Medical Journal|September 2, 2016
Zika: what we know and don't knowDoudou Diop, Dirga Sakti Rambe, Melvin Sanicas
The Pan African Medical Journal|January 11, 2021
A review of COVID-19 vaccines in development: 6 months into the pandemicMerlin Sanicas, Melvin Sanicas, Doudou Diop, et al.
The Pan African Medical Journal|March 7, 2015
A review of the surveillance systems of influenza in selected countries in the tropical regionMelvin Sanicas, Eduardo Forleo, Gianni Pozzi, et al.
Frontiers in Cellular and Infection Microbiology|December 14, 2023
Antiviral options and therapeutics against influenza: history, latest developments and future prospectsClement Meseko, Melvin Sanicas, Kumari Asha, et al.
Frontiers in Molecular Biosciences|June 16, 2023
PI3K/Akt/Nrf2 mediated cellular signaling and virus-host interactions: latest updates on the potential therapeutic management of SARS-CoV-2 infectionV S Lekshmi, Kumari Asha, Melvin Sanicas, et al.
Journal of Clinical Medicine|December 23, 2018
Advancements in Nucleic Acid Based Therapeutics against Respiratory Viral InfectionsKumari Asha, Prashant Kumar, Melvin Sanicas, et al.
Archives of Virology|January 12, 2018
The emerging influenza virus threat: status and new prospects for its therapy and controlBinod Kumar, Kumari Asha, Madhu Khanna, et al.
The Journal of Infectious Diseases|June 2, 2016
Vaccination Against Tuberculosis With Whole-Cell Mycobacterial VaccinesThomas J Scriba, Stefan H E Kaufmann, Paul Henri Lambert, et al.
Human Vaccines & Immunotherapeutics|August 14, 2020
Safety of a quadrivalent influenza vaccine in Vietnamese healthy subjects aged 6 months and olderVu Dinh Thiem, Anne-Laure Chabanon, Marion Fournier, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
The Pan African Medical Journal|July 11, 2017
[Innovations in vaccinology: challenge and opportunities for Africa]Doudou Diop, Melvin Sanicas
The Pan African Medical Journal|September 2, 2016
Zika: what we know and don't knowDoudou Diop, Dirga Sakti Rambe, Melvin Sanicas
The Pan African Medical Journal|January 11, 2021
A review of COVID-19 vaccines in development: 6 months into the pandemicMerlin Sanicas, Melvin Sanicas, Doudou Diop, et al.
The Pan African Medical Journal|March 7, 2015
A review of the surveillance systems of influenza in selected countries in the tropical regionMelvin Sanicas, Eduardo Forleo, Gianni Pozzi, et al.
Frontiers in Cellular and Infection Microbiology|December 14, 2023
Antiviral options and therapeutics against influenza: history, latest developments and future prospectsClement Meseko, Melvin Sanicas, Kumari Asha, et al.
Frontiers in Molecular Biosciences|June 16, 2023
PI3K/Akt/Nrf2 mediated cellular signaling and virus-host interactions: latest updates on the potential therapeutic management of SARS-CoV-2 infectionV S Lekshmi, Kumari Asha, Melvin Sanicas, et al.
Journal of Clinical Medicine|December 23, 2018
Advancements in Nucleic Acid Based Therapeutics against Respiratory Viral InfectionsKumari Asha, Prashant Kumar, Melvin Sanicas, et al.
Archives of Virology|January 12, 2018
The emerging influenza virus threat: status and new prospects for its therapy and controlBinod Kumar, Kumari Asha, Madhu Khanna, et al.
The Journal of Infectious Diseases|June 2, 2016
Vaccination Against Tuberculosis With Whole-Cell Mycobacterial VaccinesThomas J Scriba, Stefan H E Kaufmann, Paul Henri Lambert, et al.
Human Vaccines & Immunotherapeutics|August 14, 2020
Safety of a quadrivalent influenza vaccine in Vietnamese healthy subjects aged 6 months and olderVu Dinh Thiem, Anne-Laure Chabanon, Marion Fournier, et al.
Pageof 2